ABSTRACT
[This corrects the article DOI: 10.3892/etm.2019.7253.].
ABSTRACT
[This corrects the article DOI: 10.3892/etm.2019.7253.].
ABSTRACT
Ulcerative colitis (UC) is an important risk factor for the occurrence of colon cancer, and changes in expression of p53 and inflammatory factors are closely related to the pathogenesis of colon cancer. Therefore, changes in expression of p53 and inflammatory factors in UC were investigated to explore its intrinsic pathogenetic laws. The levels of inflammatory factors, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), IL-10 and IL-4, in peripheral blood of UC patients and healthy adults were detected via enzyme-linked immunosorbent assay, and the changes in p53 expression were analyzed via immunohistochemistry and western blotting, and the correlation of p53 expression with changes in cytokines was also analyzed. Moreover, changes in 45S preribosomal ribonucleic acid (preRNA) transcriptional activity in four kinds of cell lines exposed to IL-6 were analyzed and determined by using reverse transcription-quantitative polymerase chain reaction. Finally, the C-myc protein expression after IL-6 stimulation was analyzed and evaluated via western blot analysis. The levels of IL-6 and TNF-α in peripheral blood in the UC patient group were significantly increased compared with those in the healthy adult group (P<0.01), while the levels of IL-10 and IL-4 in peripheral blood were significantly decreased compared with those in the healthy adult group (P<0.01). The p53 expression had a significant negative correlation with IL-6. The results showed that IL-6 activated C-myc messenger RNA (mRNA) translation, thereby upregulating the ribosomal RNA (rRNA) transcription. Additionally, IL-6 stimulated the mouse double minute 2 homolog (MDM2)-mediated proteasomal degradation of p53 by reducing the availability of ribosomal protein used for MDM2 binding, thus resulting in the downregulation of p53 protein expression. The findings of the study show that, expression level of IL-6 was increased in UC patients, which regulates the downregulation of p53 expression level and plays a role in tumorigenesis through enhancing cell proliferation and inhibiting apoptosis.
ABSTRACT
This study investigated the effect of glucocorticoids combined with probiotics on inflammatory factors and intestinal microflora in the treatment of Crohn's disease. Eighty-three patients with Crohn's disease were selected from March 2015 to December 2017 in PLA Army General Hospital (Beijing, China). A total of 83 patients were randomly divided into the control group and treatment group. Patients in the control group were treated with routine treatment of oral sulfasalazine. Besides oral sulfasalazine, patients in the treatment group were treated with probiotics combined with glucocorticoids. At the same time, a total of 40 healthy individuals were selected to serve as the healthy group (received no treatment). Clinical efficacy, changes of inflammatory factors, incidence of infection and changes of intestinal flora were compared between the different groups. After treatment, the levels of inflammatory factors in both groups significantly decreased, and the reduction in the treatment group significantly increased than that in the control group (P<0.05). The levels of inflammatory cytokines in the treatment group reached the levels of that in the healthy individuals after treatment. After treatment, the levels of yeast, enterococci and peptococcus of the two groups of patients were significantly decreased, while the level of lactobacillus was significantly increased, and the changes were more significant in the treatment group than those in the control group. After treatment, the number of intestinal flora in the treatment group reached that of the healthy individuals. Treatment efficiency of the treatment group was significantly higher than that of the control group, and the infection rate of the control group was significantly higher than that of the treatment group (P<0.05). The use of probiotics combined with glucocorticoid in the treatment of Crohn's disease can improve clinical curative effect, reduce the secretion of inflammatory factors and improve the level of intestinal flora, so as to achieve better outcomes compared with conventional method.
ABSTRACT
Cronkhite-Canada syndrome (CCS) is a rare but serious protein-losing enteropathy, but little is known about the mechanism. Further more, misdiagnosis is common due to non-familiarity of its clinical manifestation. A 40-year-old male patient was admitted to our hospital because of diarrhea and hypogeusia associated with weight loss for 4 mo. On physical examination, skin pigmentation, dystrophic nail changes and alopecia were noted. He had no alike family history. Laboratory results revealed low levels of serum albumin (30.1 g/L, range: 35.0-55.0 g/L), serum potassium (2.61 mmol/L, range: 3.5-5.5 mmol/L) and blood glucose (2.6 mmol/L, range: 3.9-6.1 mmol/L). The erythrocyte sedimentation rate was elevated to 17 mm/h (range: 0-15 mm/h). X-ray of chest and mandible was normal. The endoscopic examination showed multiple sessile polyps in the stomach, small bowel and colorectum. Histopathologic examination of biopsies obtained from those polyps showed hyperplastic change, cystic dilatation and distortion of glands with inflammatory infiltration, eosinophilic predominance and stromal edema. Immune staining for IgG4 plasma cells was positive in polyps of stomach and colon. The patient was diagnosed of CCS and treated with steroid, he had a good response to steroid. Both histologic findings and treatment response to steroid suggested an autoimmune mechanism underling CCS.
ABSTRACT
Nanotube-nanoparticle composites are fabricated by template-directed automatic layer-by-layer assembly with the assistance of pressure. This assembly strategy above allows the facile construction of uniform complex nanostructures with ultra-multilayers (≈200). Importantly, it takes much less time than conventional manual manipulation.
ABSTRACT
Immunoglobulin G4 (IgG4)-related disease is a rare systemic diseases. A 67-year-old male presented at our institution with mild upper abdominal pain and jaundice for 20 d. Laboratory results revealed high levels of IgG4 (15.4 g/L, range: 0.08-1.4 g/L). Computed tomography (CT) showed significant enlargement of the entire pancreas and a capsule-like low-density rim surrounding the whole pancreas. Positron emission tomography/CT revealed increased uneven metabolism of the entire pancreas. Both magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography showed stenosis of the distal common bile duct and proximal main pancreatic duct, and dilation of the proximal common bile duct and extra- and intra-hepatic bile ducts. He was diagnosed with IgG4-related autoimmune pancreatitis. The patient was treated with prednisone for 14 mo. The patient responded well to prednisone but upon cessation of the corticosteroid developed enlargement of the submandibular gland. The patient's serum IgG4 was elevated at 23.9 g/L. It is important to maintain treatment, so the patient was again treated with prednisone and had a good response. Follow-up of IgG4-related disease is thus necessary.
Subject(s)
Autoimmune Diseases/immunology , Immunoglobulin G/blood , Pancreatitis/immunology , Sialadenitis/immunology , Aged , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/drug therapy , Biomarkers/blood , Cholangiopancreatography, Endoscopic Retrograde , Cholangiopancreatography, Magnetic Resonance , Glucocorticoids/therapeutic use , Humans , Male , Pancreatitis/blood , Pancreatitis/diagnosis , Pancreatitis/drug therapy , Positron-Emission Tomography , Predictive Value of Tests , Prednisone/therapeutic use , Sialadenitis/blood , Sialadenitis/diagnosis , Sialadenitis/drug therapy , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Peutz-Jeghers syndrome (PJS) is a rare, inherited autosomal dominant disease characterized by mucocutaneous pigmentation and polyps in the gastrointestinal tract. Here, we report the rare case of a 64-year-old female patient with pigmentation on her lips and extremities for over 63 years and intermittent abdominal pain and, diarrhea for 3 years. The presence of intestinal and colorectal hamartomatous polyps was confirmed. The removal and characterization of her rectal polyp showed it to be a typical hamartomatous polyp with a portion of it being an adenoma with high-grade intramucosal neoplasia. A survey of the patient's family identified 9 people in the family with Peutz-Jeghers syndrome and three of them have already died from colorectal cancer. This case study serves as an example of how imperative it is to survey the patient about their family history in order to detect early cancerous lesions.
Subject(s)
Adenomatous Polyps/pathology , Colonic Polyps/pathology , Colorectal Neoplasms/pathology , Intestinal Mucosa/pathology , Peutz-Jeghers Syndrome/pathology , Adenomatous Polyps/genetics , Biopsy , Colonic Polyps/genetics , Colonoscopy , Colorectal Neoplasms/genetics , Female , Genetic Predisposition to Disease , Heredity , Humans , Male , Middle Aged , Pedigree , Peutz-Jeghers Syndrome/genetics , PhenotypeABSTRACT
AIM: To evaluate clinical response to initial corticosteroid (CS) treatment in Chinese ulcerative colitis patients (UC) and identify predictors of clinical response. METHODS: Four hundred and twenty-three UC patients who were initially treated with oral or intravenous CS from 2007 to 2011 were retrospectively reviewed at eight inflammatory bowel disease centers in China, and 101 consecutive cases with one-year follow-up were analyzed further for clinical response and predictors. Short-term outcomes within one month were classified as primary response and primary non-response. Long-term outcomes within one year were classified as prolonged CS response, CS dependence and secondary non-response. CS refractoriness included primary and secondary non-response. Multivariate analyses were performed to identify predictors associated with clinical response. RESULTS: Within one month, 95.0% and 5.0% of the cases were classified into primary response and non-response, respectively. Within one year, 41.6% of cases were assessed as prolonged CS response, while 49.5% as CS dependence and 4.0% as secondary non-response. The rate of CS refractoriness was 8.9%, while the cumulative rate of surgery was 6.9% within one year. After multivariate analysis of all the variables, tenesmus was found to be a negative predictor of CS dependence (OR = 0.336; 95%CI: 0.147-0.768; P = 0.013) and weight loss as a predictor of CS refractoriness (OR = 5.662; 95%CI: 1.111-28.857; P = 0.040). After one-month treatment, sustained high Sutherland score (≥ 6) also predicted CS dependence (OR = 2.347; 95%CI: 0.935-5.890; P = 0.014). CONCLUSION: Tenesmus was a negative predictor of CS dependence, while weight loss and sustained high Sutherland score were strongly associated with poor CS response.
Subject(s)
Adrenal Cortex Hormones/therapeutic use , Colitis, Ulcerative/drug therapy , Adrenal Cortex Hormones/adverse effects , Adult , Chi-Square Distribution , China , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/surgery , Female , Humans , Logistic Models , Male , Multivariate Analysis , Odds Ratio , Recurrence , Remission Induction , Retrospective Studies , Severity of Illness Index , Time Factors , Treatment Outcome , Weight LossABSTRACT
AIM: To explore the dynamic changes of prion protein (PrPc) in the process of gastric cancer drug resistance and the role of PrPc expression in the prognosis of gastric cancer patients receiving chemotherapy. METHODS: A series of gastric cancer cell lines resistant to different concentrations of adriamycin was established, and the expression of PrPc, Bcl-2 and Bax was detected in these cells. Apoptosis was determined using Annexin V staining. Western blotting and immunohistochemistry were performed to detect the expression of PrPc in patients receiving chemotherapy and to explore the role of PrPc expression in predicting the chemosensitivity and the outcome of gastric cancer patients receiving chemotherapy. Follow-up was performed for 2 years. RESULTS: PrPc expression was increased with the increase in drug resistance. Bcl-2, together with PrPc, increased the level of anti-apoptosis of cancer cells. Increased PrPc expression predicted the enhanced level of anti-apoptosis and resistance to anticancer drugs. PrPc expression could be used as a marker for predicting the efficacy of chemotherapy and the prognosis of gastric cancer. Increased PrPc expression predicted both poor chemosensitivity and a low 2-year survival rate. Contrarily, low PrPc expression predicted favorable chemosensitivity and a relatively high 2-year survival rate. CONCLUSION: PrPc expression is associated with histological types and differentiation of gastric cancer cells; The PrPc expression level might be a valuable marker in predicting the efficacy of chemotherapy and the prognosis of gastric cancer patients receiving chemotherapy.
Subject(s)
Drug Resistance, Neoplasm/physiology , PrPC Proteins/metabolism , Stomach Neoplasms/metabolism , Stomach Neoplasms/physiopathology , Adult , Aged , Animals , Antineoplastic Agents/therapeutic use , Apoptosis , Cell Line, Tumor , Doxorubicin/therapeutic use , Female , Humans , Male , Microarray Analysis , Middle Aged , Prognosis , Proto-Oncogene Proteins c-bcl-2/metabolism , Stomach Neoplasms/diagnosis , Stomach Neoplasms/drug therapy , bcl-2-Associated X Protein/metabolismABSTRACT
AIM: To study the characteristics of APC (adenomatous polyposis coli) gene germline mutation in Chinese patients with familial adenomatous polyposis (FAP). METHODS: APC gene from 14 FAP families was amplified by polymerase chain reaction (PCR) and underwent direct sequencing to determine the micromutation type. For the samples without micromutation, the large fragment deletion of APC gene was examined by multiplex ligation-dependent probe amplification (MLPA). RESULTS: There were gene micromutations in 9 families with a micromutation detection rate of 64.3% (9/14), including 6 frameshift mutations (66.7%), 1 nonsense mutation (11.1%) and 2 splicing mutations (22.2%). Large fragment deletions were detected by MLPA in 2 families. The total mutation detection rate of micromutations and large fragment deletions was 78.6% (11/14). CONCLUSION: The detection rate of APC gene germline mutation can be improved by direct sequencing combined with MLPA large fragment deletion detection.
Subject(s)
Adenomatous Polyposis Coli/genetics , Genes, APC , Mutation , Adenomatous Polyposis Coli/ethnology , Adolescent , Adult , Asian People/genetics , Child , China/epidemiology , Codon, Nonsense , DNA Mutational Analysis , Exons , Female , Frameshift Mutation , Gene Deletion , Gene Expression Regulation, Neoplastic , Genetic Predisposition to Disease , Germ-Line Mutation , Humans , Male , Middle Aged , Pedigree , Risk Factors , Young AdultABSTRACT
Cryptophane-E was synthesized from vanillin by a three-step method, and its absorption and fluorescence spectroscopic properties were determined. Two absorption bands at about 245-260 and 280-290 nm were observed for cryptophane-E and the fluorescence emission maxima were at 320-330 nm depending on the solvent used. The interaction of cryptophane-E with CHCl(3) was studied in detail by absorption and fluorescence spectroscopies. The results showed that cryptophane-E and CHCl(3) can easily form a stable 1:1 host-guest inclusion complex. Their binding constant (K) was determined by Benesi-Hildebrand equation and the nonlinear least squares fit method. The binding constant is largest in ethyl acetate, followed by dioxane and with acetonitrile as the smallest. In addition, the effect of guest volume on the host-guest inclusion complex was investigated. Guest molecules including CH(2)Cl(2) and CCl(4) were unable to form inclusion complex with cryptophane-E because of sizes mismatching with the host cavity.
Subject(s)
Chlorides/chemistry , Chloroform/chemistry , Polycyclic Compounds/chemistry , Spectrometry, Fluorescence/methods , Absorption , Antioxidants/chemistry , Benzaldehydes/chemistry , Models, Molecular , Molecular Structure , Polycyclic Compounds/chemical synthesis , Solvents/chemistryABSTRACT
A group of novel cage-like compounds cryptophanes A and E were synthesized from vanillin by a three-step method. The intermolecular interaction between cryptophanes (A and E) and fullerene (C(60)) was investigated in detail by absorption, fluorescence and (1)H NMR spectroscopy. The absorption of C(60) at 410-650 nm decreased in the presence of cryptophanes A or E. The decrease in absorption intensity was proportional to the concentration of cryptophanes A or E. On the other hand, the fluorescence intensity of cryptophanes A or E decreased and the emission maxima were blue-shifted with the increase in C(60) concentration. These results suggest that contact charge transfer (CCT) complexes can be formed from C(60) with cryptophanes A or E. In addition, the electrochemical behavior of cryptophanes (A and E) and C(60) was studied by cyclic voltammetry. The redox currents of cryptophanes (A and E) decreased and the peak potentials were shifted on addition of C(60). The changes in the chemical shifts (Delta delta) of aromatic protons of cryptophanes (A and E) in their NMR spectra further support that CCT complexes were formed with cryptophanes as the electron donors and C(60) as the electron acceptor.
Subject(s)
Fullerenes/chemistry , Polycyclic Compounds/chemistry , Triazoles/chemistry , Absorption , Magnetic Resonance Spectroscopy , Oxidation-Reduction , Polycyclic Compounds/chemical synthesis , Spectrometry, FluorescenceABSTRACT
BACKGROUND AND OBJECTIVES: Detection of colorectal exfoliated epithelial cells and their nuclear DNA content may provide another non-invasive way of screening and early diagnosis of colorectal cancer. This study was designed to analyze the roles of exfoliated cells in stool and its nuclear DNA content in diagnosis of colorectal cancer. METHODS: 1. One hundred and seventy nine individuals were selected, forty-six of them had pathological confirmation of colorectal carcinoma. The other 133 persons had no colonoscopic evidence of colorectal malignancy and therefore served as control. Exfoliated cells in the stool were isolated by elutriation, and the elutriation means was modified Iyengar's method. All individuals in the study had stool specimens for occult blood test(FOBT). 2. Nuclear DNA content and morphometric quantitative analysis in the exfoliated cells was performed on the 33 patients with colorectal cancer and 30 individuals served as control. The parameters selected in this study were DNA content, nuclear area, nuclear irregular index, and percent of > or = 5C cells. RESULTS: 1 Exfoliative cytology and FOBT: In 35 of 46 cases of colorectal malignancy(76.09%), cytology was positive: 5 cases demonstrated dysplastic cells, 4 cases indicated suspected carcinoma cells, 26 cases showed carcinoma cells. The positive rate of exfoliated cells had no significant relation to locations, sizes, histomorphologies, histological differentiations, Dukes stages, and lymph node metastases of the lesion(P > 0.05). Exfoliative cytology had a 98.50% (131/133) specificity for colorectal cancer in the study. The sensitivity for colorectal cancer was no significant difference between the two methods of exfoliative cytology and FOBT (76.09% vs 84.78%, P > 0.05), but the specificity for colorectal cancer, exfoliative cytology was significant higher than FOBT(98.50% vs 73.68%, P < 0.05). 2. DNA analysis of exfoliated cells nuclear, DNA content, nuclear area, nuclear irregular index and percent of > or = 5C cells in the stool were significant higher in colorectal cancer than in control group(P < 0.05). The percentage of > or = 5C cells were significantly associated with histological grade (P < 0.05). CONCLUSIONS: 1. Detection of exfoliated cells in stool plays an important role in diagnosis of colorectal cancer. Testing of FOBT and exfoliated cells sequentially hopes to be a new useful non-invasive test for screening of colorectal cancer. 2. DNA analysis of exfoliated cell in stool may provide an objective method of determining malignant grades and diagnosis of colorectal cancer.